WBIO — WPD Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

FinancialsHighly SpeculativeMicro Cap

Annual balance sheet for WPD Pharmaceuticals, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	2.95	1.24	0.301	0.024	0.086
Net Total Accounts Receivable
Net Total Receivables	0.222	0.04	0.034	0.052	0.033
Prepaid Expenses
Total Other Current Assets
Total Current Assets	3.18	1.94	1.8	0.076	0.122
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.087	0.087	0.065	0	—
Net Intangible Assets
Long Term Investments
Total Assets	4.07	2.68	1.86	0.076	0.346
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	0.864	1.58	5.92	0.555	0.598
Long Term Debt
Total Long Term Debt
Total Debt
Total Liabilities	0.864	1.58	5.92	0.555	0.902
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	3.21	1.11	-4.06	-0.479	-0.556
Total Liabilities & Shareholders' Equity	4.07	2.68	1.86	0.076	0.346
Total Common Shares Outstanding